Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 7, 2006

View Archived Issues

Nostrum obtains rights to clot busting therapeutic protein from IMTECH

AstraZeneca gives lowdown on second quarter

Gardant updates acquisition and spin-off details

Pozen and AstraZeneca to develop esomeprazole/naproxen fixed dose combinations

Preterm birth prevention study of Prochieve completes enrollment

Phase II study of IR-103 in HIV patients cleared to add French sites

Oncaspar in combination with Gemzar begins phase I study

Enzon's IND approved for recombinant human mannose-binding lectin

Phase IIb study to assess PEP-005 Topical in actinic keratosis

Archemix and Nuvelo expand aptamer collaboration

CHDI and Edison team up to develop therapeutics for Huntington's disease

Satraplatin studied with Tarceva in phase II NSCLC trial

In vivo data show antiviral activity of AC-03-636

Phase IIb stroke study of DP-b99 completes enrollment

Alzheimer's candidate AZD-103 cleared for phase I study

BTA-798 for human rhinovirus advances through phase I testing

VAS-2870: novel NOX inhibitor for cardiovascular disease

Alemtuzumab to be tested in new phase II study for T-cell large granular lymphocytic leukemia

SAHA shows promise for the treatment of SMA

Positive phase I results of CI-1033 in combination with docetaxel in solid tumors reported

Novel antiviral agents reported in recent Shionogi patent

New analgesic agents reported in recent Schwarz patent

Recent patents cover novel BACE inhibitors for Alzheimer's disease

Recent patents describe new agents for anxiety, sleep disorders, etc.

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...